Federal award
ORTHO-CLINICAL DIAGNOSTICS, INC
W81K0209F0005
Contract
Obligated and Ceiling
- Obligated (net)
- $4,190,841.38
- Ceiling (potential value, not spending)
- $5,040,866.38
- Current value
- $4,190,841.38
- Gross positive obligations
- $4,718,897.45
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ORTHO-CLINICAL DIAGNOSTICS, INC · JG5JF2JQJ121
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- JOHNSON & JOHNSON HEALTHCARE · LKV3QN1ND7D1
- Awarding agency
- Department of War · sub-agency 2100 · office W81K02
- Funding agency
- Department of War · sub-agency 2100
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W81K0209F0005
- Parent vehicle (IDV PIID)
- V797P7126A
- Award type code
- C
- Actions
- 14 · Jan 13, 2009 to Sep 15, 2017
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History14
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Sep 15, 2017 | FY2017 | P00013 | K | −$146,842.92 | — |
| Sep 28, 2012 | FY2012 | P00012 | B | −$9,678.77 | — |
| Nov 22, 2011 | FY2012 | P00011 | C | $1,347,928.03 | — |
| Sep 29, 2011 | FY2011 | P00010 | B | $180,110.53 | — |
| Sep 13, 2011 | FY2011 | P00009 | G | $0.00 | — |
| Oct 28, 2010 | FY2011 | P00008 | C | $1,191,474.32 | — |
| Sep 28, 2010 | FY2010 | P00007 | B | $213,256.07 | — |
| Sep 28, 2010 | FY2010 | P00006 | G | $0.00 | — |
| May 14, 2010 | FY2010 | P00005 | B | $0.00 | — |
| Oct 6, 2009 | FY2010 | P00004 | C | $921,919.36 | — |
| Sep 25, 2009 | FY2009 | P00003 | B | −$371,534.38 | — |
| Sep 11, 2009 | FY2009 | P00002 | G | $0.00 | — |
| May 15, 2009 | FY2009 | P00001 | D | $0.00 | — |
| Jan 13, 2009 | FY2009 | 0 | — | $864,209.14 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.